Therefore, a pairwise correlation of the PI3K/AKT/mTOR pathway members was performed in GBM PDX upon PBS (control), TMZ, bevacizumab, regorafenib and TMZ/ regorafenib treatment (Fig. 3A-E). Here, MTOR is linked to glioblastoma.